PERSKY MARLA

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 38% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PERSKY MARLA's trades of Xeris Biopharma Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-03
PrS Proposed sale
82,086
274.02
US$3,974,651 		82,086 274.02 US$3,974,651
2025-09-12 2025-09-11
PlS Planned sale
47,684 +26.4%
489.57
US$3,298,318 		47,684 +26.4% 489.57 US$3,298,318
2025-09-11 2025-09-11
PrS Proposed sale
57,391
353.52
US$2,931,316 		57,391 353.52 US$2,931,316
2023-11-15 2023-11-14
B Purchase
6,370 +inf%
1.58
US$10,058 		6,370 +inf% 1.58 US$10,058